Biophenotypes and survival of BRCA1 and TP53 deleted breast cancer in young women

Breast Cancer Research and Treatment

Volumn 66, Issue 2, 2001, Pages 135-142

  Querzoli, P ^a   Albonico, G ^a   Iasio, M G D ^a   Ferretti, S ^a   Rinaldi, R ^a   Cariello, A ^b   Pedriali, M ^a   Matteuzzi, M ^a   Maestri, I ^a   Nenci, I ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b Division of Oncology   (Italy)

Author keywords

BRCA1; D17S786; D17S855; Early onset breast cancer; LOH; Prognosis; TP53

Indexed keywords

BIOLOGICAL MARKER; MICROSATELLITE DNA; PROTEIN P53;

ADULT; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER GRADING; CANCER PATIENT; CANCER RECURRENCE; CANCER SURVIVAL; CORRELATION FUNCTION; EARLY CANCER; FEMALE; FOLLOW UP; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MITOSIS RATE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR VOLUME;

ADULT; AGE FACTORS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; FEMALE; GENES, BRCA1; GENES, P53; HUMANS; IMMUNOHISTOCHEMISTRY; ITALY; LOSS OF HETEROZYGOSITY; MIDDLE AGED; PHENOTYPE; POLYMERASE CHAIN REACTION; SURVIVAL ANALYSIS;

EID: 0035006457     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1010643515095     Document Type: Article

References (41)

1. Inherited BRCA2 mutation associated with high grade breast cancer
2. Early-onset breast cancer-histopathological and prognostic considerations
3. Breast carcinomas occurring in young women (< 35 years) are different
4. Age as a prognostic factor in premenopausal breast carcinoma
5. Younger women with breast carcinoma have a poorer prognosis than older women
6. Expression and function of BRCA1 and BRCA2 in familial and sporadic breast cancer
7. Linkage of early-onset familial breast cancer to chromosome 17q21
8. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1
9. Insights into the functions of BRCA1 and BRCA2
10. BRCA1 and BRCA2 proteins: Roles in health and disease
11. The p53 tumor suppressor gene in breast cancer
12. P53 and breast cancer
13. Hereditary cancers: Clues to mechanisms of carcinogenesis
14. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: Experience from a large study with long-term follow-up
15. Pratical histological microdissection for PCR analysis
16. Microdissection and polymerase chain reaction amplification of genomic DNA from histological tissue sections
17. Rapid detection of allele loss in colorectal tumors using microsatellites and fluorescent DNA technology
18. Quantitative immunoprofiles of breast cancer performed by image analysis
19. Application of quantitative analysis to biologic profile evaluation in breast cancer
20. A computer program for comparing k samples with right censored data
21. Modulation of biomarkers in minimal breast carcinoma: A model for human breast carcinoma progression
22. Distinct molecular pathogeneses of early-onset breast cancers in BRCA1 and BRCA2 mutation carriers: A population-based study
23. Patterns of allelic loss on chromosome 17 in sporadic breast carcinomas detected by fluorescent-labeled microsatellite analysis
24. Genetic alteration on chromosome 17 in human breast cancer: Relationships to clinical features and DNA ploidy
25. Genome-wide search for loss of heterozygosity shows extensive genetic diversity of human breast carcinomas
26. Frequency of BRCA1/BRCA2 mutations in a population-based sample of young breast carcinoma cases
27. Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression
28. Complete genomic sequence and analysis of 117 kb of human DNA containing the gene BRCA1
29. TP53 mutations and abnormal p53 protein staining in breast carcinomas related to prognosis
30. Genomic instability and poor prognosis associated with abnormal TP53 in breast carcinomas. Molecular and immunohistochemical analysis
31. Loss of heterozygosity at the TP53 gene: Independent occurrence from genetic instability events in node-negative breast cancer
32. P53 protein expression in mammary ductal carcinoma in situ: Relationship to immunohistochemical expression of estrogen receptor and c-erbB-2 protein
33. Intraductal component and BRCA1-associated breast cancer
34. Survival in early-onset BRCA1 breast-cancer patients
35. Germ-line BRCA1 mutation is an adverse prognostic factor in Ashkenazi Jewish women with breast cancer
36. Hereditary breast cancer: Pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage
37. Pathology and heredity of breast cancer in younger women
38. BRCA-associated breast cancer in young women
39. Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1
40. Primary node negative breast cancer in BRCA1 mutation carriers has a poor outcome